Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
2003
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment
2015 Standout
Action Plan for Stroke in Europe 2018–2030
2018 Standout
Pathobiology of ischaemic stroke: an integrated view
1999 Standout
Hemorrhagic infarct conversion in experimental stroke
1992
Tissue Plasminogen Activator
1988
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Intra-arterial Prourokinase for Acute Ischemic Stroke
1999 Standout
Stroke
2008 Standout
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
1998 Standout
Thrombolytic Therapy: Current Status
1988
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
Frontal-Subcortical Circuits and Human Behavior
1993 Standout
Negative Fluid-Attenuated Inversion Recovery- Based Intravenous Thrombolysis Using Recombinant Tissue Plasminogen Activator in Acute Stroke Patients with Unknown Onset Time
2013 Standout
Thrombolytic therapy in cerebrovascular disorders
1992
Endovascular Stroke Therapy Results Improve over Time: The ‘Learning Curve' at a New Comprehensive Stoke Center
2015 Standout
Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation
1989
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
2000 Standout
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
2010 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
2000 Standout
Vertebrobasilar thrombosis
1996
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Use of ancrod in acute or progressing ischemic cerebral infarction
1988
Advances in Thrombolytic Therapy
1982
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Neuroprotection in stroke: the importance of collaboration and reproducibility
2017
The `subcortical dementia' of progressive supranuclear palsy
1974
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 Standout
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
2006 Standout
Thrombolysis in acute ischemic stroke: does it work?
1992
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.
1994
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
1993
Short-Term Synaptic Plasticity
2002 Standout
Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
1990
Varicella-zoster virus
1996 Standout
The AIDS dementia complex: I. Clinical features
1986 Standout
Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients
2001 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2010 Standout
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.
1994
Trial Design and Reporting Standards for Intraarterial Cerebral Thrombolysis for Acute Ischemic Stroke
2003
Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.
1988
Resting transmembrane potential difference of skeletal muscle in normal subjects and severely ill patients
1971
Predictors of Clinical Improvement, Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
1999
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.
1988
An Updated Definition of Stroke for the 21st Century
2013 Standout
Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.
1988
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
2009 Standout
The Impact of Recanalization on Ischemic Stroke Outcome
2007 Standout
Organization and synaptic physiology of crustacean neuromuscular systems
1976
Tissue Plasminogen Activator Reduces Neurological Damage After Cerebral Embolism
1985 Science
Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke
1996
Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.
1986 StandoutNobel
Works of John E. Brooks being referenced
Reperfusion Is a Stronger Predictor of Good Clinical Outcome than Recanalization in Ischemic Stroke
2013
Intracellular Electromyography
1968
Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke.
1976
DEFECTIVE RAPID EYE MOVEMENTS IN PROGRESSIVE SUPRANUCLEAR PALSY
1970
Disuse Atrophy of Muscle
1970
Handbook of Clinical Neurology
1972
A pilot study of urokinase therapy in cerebral infarction.
1976